Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-31false2024-04-01No description of principal activityThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2false2truetrue 09500148 2024-04-01 2025-03-31 09500148 2023-04-01 2024-03-31 09500148 2025-03-31 09500148 2024-03-31 09500148 c:Director1 2024-04-01 2025-03-31 09500148 d:Buildings 2024-04-01 2025-03-31 09500148 d:Buildings 2025-03-31 09500148 d:Buildings 2024-03-31 09500148 d:Buildings d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 09500148 d:Buildings d:LeasedAssetsHeldAsLessee 2024-04-01 2025-03-31 09500148 d:MotorVehicles 2024-04-01 2025-03-31 09500148 d:MotorVehicles 2025-03-31 09500148 d:MotorVehicles 2024-03-31 09500148 d:MotorVehicles d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 09500148 d:MotorVehicles d:LeasedAssetsHeldAsLessee 2024-04-01 2025-03-31 09500148 d:FurnitureFittings 2024-04-01 2025-03-31 09500148 d:FurnitureFittings 2025-03-31 09500148 d:FurnitureFittings 2024-03-31 09500148 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 09500148 d:FurnitureFittings d:LeasedAssetsHeldAsLessee 2024-04-01 2025-03-31 09500148 d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 09500148 d:LeasedAssetsHeldAsLessee 2024-04-01 2025-03-31 09500148 d:CurrentFinancialInstruments 2025-03-31 09500148 d:CurrentFinancialInstruments 2024-03-31 09500148 d:Non-currentFinancialInstruments 2025-03-31 09500148 d:Non-currentFinancialInstruments 2024-03-31 09500148 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 09500148 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 09500148 d:Non-currentFinancialInstruments d:AfterOneYear 2025-03-31 09500148 d:Non-currentFinancialInstruments d:AfterOneYear 2024-03-31 09500148 d:ShareCapital 2025-03-31 09500148 d:ShareCapital 2024-03-31 09500148 d:RetainedEarningsAccumulatedLosses 2025-03-31 09500148 d:RetainedEarningsAccumulatedLosses 2024-03-31 09500148 c:FRS102 2024-04-01 2025-03-31 09500148 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 09500148 c:FullAccounts 2024-04-01 2025-03-31 09500148 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09500148 d:HirePurchaseContracts d:WithinOneYear 2025-03-31 09500148 d:HirePurchaseContracts d:WithinOneYear 2024-03-31 09500148 d:HirePurchaseContracts d:BetweenOneFiveYears 2025-03-31 09500148 d:HirePurchaseContracts d:BetweenOneFiveYears 2024-03-31 09500148 d:MotorVehicles d:LeasedAssetsHeldAsLessee 2025-03-31 09500148 d:MotorVehicles d:LeasedAssetsHeldAsLessee 2024-03-31 09500148 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Registered number: 09500148









J&R MEDICAL SERVICES LIMITED







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

 
J&R MEDICAL SERVICES LIMITED
REGISTERED NUMBER: 09500148

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 4 
86,477
117,008

Current assets
  

Debtors: amounts falling due within one year
 5 
77,467
105,475

Cash at bank and in hand
  
202,309
227,740

  
279,776
333,215

Creditors: amounts falling due within one year
 6 
(34,553)
(58,744)

Net current assets
  
 
 
245,223
 
 
274,471

Total assets less current liabilities
  
331,700
391,479

Creditors: amounts falling due after more than one year
 7 
(67,503)
(81,178)

Provisions for liabilities
  

Deferred tax
  
(11,054)
(26,510)

Net assets
  
253,143
283,791


Capital and reserves
  

Called up share capital 
  
200
200

Profit and loss account
  
252,943
283,591

  
253,143
283,791


Page 1

 
J&R MEDICAL SERVICES LIMITED
REGISTERED NUMBER: 09500148
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 25 October 2025.




Dr J Chandrasenan
Director

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
J&R MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

The company is a private limited company, which is incorporated and registered in England (registration
number: 09500148). The address of the registered office is Cromwell House, 68 West Gate, Mansfield,
Nottinghamshire, NG18 1RR.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Going concern

The financial statements have been prepared on the going concern basis. The directors believe that the company has sufficient resources to be able to continue to trade until at least December 2026.

At the time of signing there is a degree of uncertainty about the cost of living and wider geopolictical issues. The directors continue to monitor the position closely, however believe that the company will continue at an appropriate level of activity subject to their continued support.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

 
J&R MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.4

Operating leases: the company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.5

Pensions

Defined contribution pension plan

The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.

 
2.6

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Page 4

 
J&R MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Freehold property
-
10% straight line basis
Motor vehicles
-
25% straight line basis
Fixtures and fittings
-
25% reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.


3.


Employees

The average monthly number of employees, including the directors, during the year was as follows:


        2025
        2024
            No.
           No.







2
2

Page 5

 
J&R MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

4.


Tangible fixed assets





Freehold property
Motor vehicles
Fixtures and fittings
Total

£
£
£
£



Cost or valuation


At 1 April 2024
34,320
105,343
30,946
170,609


Additions
-
-
830
830



At 31 March 2025

34,320
105,343
31,776
171,439



Depreciation


At 1 April 2024
20,166
10,973
22,462
53,601


Charge for the year on owned assets
2,693
-
2,332
5,025


Charge for the year on financed assets
-
26,336
-
26,336



At 31 March 2025

22,859
37,309
24,794
84,962



Net book value



At 31 March 2025
11,461
68,034
6,982
86,477



At 31 March 2024
14,154
94,370
8,484
117,008

Page 6

 
J&R MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

           4.Tangible fixed assets (continued)

The net book value of assets held under finance leases or hire purchase contracts, included above, are as follows:


2025
2024
£
£



Motor vehicles
68,034
94,370


5.


Debtors

2025
2024
£
£


Trade debtors
71,843
98,705

Other debtors
76
-

Prepayments and accrued income
5,548
4,640

Tax recoverable
-
2,130

77,467
105,475



6.


Creditors: Amounts falling due within one year

2025
2024
£
£

Other taxation and social security
18,307
28,998

Obligations under finance lease and hire purchase contracts
13,674
13,674

Other creditors
109
11,922

Accruals and deferred income
2,463
4,150

34,553
58,744


The following liabilities were secured:

2025
2024
£
£



HP Liability
13,674
13,674

Details of security provided:

The HP liability is secured on the related asset.

Page 7

 
J&R MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

7.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Net obligations under finance leases and hire purchase contracts
67,503
81,178


The following liabilities were secured:

2025
2024
£
£



HP Liability
67,503
81,178

Details of security provided:

The HP liability is secured on the related asset.


8.


Hire purchase and finance leases


Minimum lease payments under hire purchase fall due as follows:

2025
2024
£
£


Within one year
13,674
13,674

Between 1-5 years
67,503
81,178

81,177
94,852


9.


Pension commitments

The company operates a defined contributions pension scheme.The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund and amounted to £24,000 (2024 - £24,000). There were contributions totalling £nil (2024 - £nil) payable to the fund at the balance sheet date.

 
Page 8